Objective Red blood cell distribution width (RDW) is a numerical measure of erythrocyte size variation. It has been recently reported to be an independent prognostic marker of heart failure (HF). Previous studies on RDW were mostly designed for middle-aged and elderly patients (60-79 years old), therefore, there is no established limit for super-elderly patients (! 80 years old). The purpose of this study was to evaluate RDW as an effective tool to detect fatal HF in super-elderly patients. Methods The medical records and death certificates of 160 consecutive patients admitted to the Department of Cardiology in Juntendo Tokyo Koto Geriatric Medical Center and who died from June 2002 to October 2010 were reviewed. The causes of death were reviewed, and the factors, including RDW, that might have been related to the fatal HF were evaluated using multivariate logistic regression analysis. Results HF was the major cause of death [52 patients (32.5%), 29 females, age 84.0±7.5 years], followed by pneumonia (18.8%, 30/160), and acute myocardial infarction (16.3%, 26/160). The most common cause of HF was atrial fibrillation (36.6%, 19/52), followed by hypertensive heart disease (19.2%, 10/52) and valvular disorders (17.3%, 9/52). The multivariate logistic regression analysis found that a high RDW (! 16.5%) was an independent factor related to fatal HF (OR 2.36, 95% CI 1.10, 5.04, p=0.03). Conclusion HF was the major cause of death, and RDW ! 16.5 was significantly associated with fatal HF in super-elderly patients.
Introduction
Red blood cell distribution width (RDW) is a numerical measure of erythrocyte size variation. RDW is routinely assessed as part of the complete blood count and is generally used as an indicator in the differential diagnosis of anemia (1, 2) . Recently, RDW has been reported to be an independent prognostic marker of heart failure (HF), cardiovascular events, and mortality (3) (4) (5) . Previous studies on RDW
Materials and Methods

Study patients and setting
Consecutive patients from June 2002 to October 2010 admitted to the Department of Cardiology and who died in Juntendo Tokyo Koto Geriatric Medical Center were retrospectively evaluated. The study was approved by the Institutional Ethics Committee of Juntendo Tokyo Koto Geriatric Medical Center.
Cause of death
The causes of death were identified by reviewing medical charts and rechecked with death certificates. They were divided into three categories: fatal HF, cardiovascular disease (CVD) without fatal HF, and non-CVD.
Analysis of RDW
First, the RDW values were compared between patients with fatal HF and patients without fatal HF. Second, the cutoff value of RDW for fatal HF was investigated by univariate analyses with different cut-off points, i.e., dichotomized RDW value, with increments of 0.5 percentage points from 14.0% to 16 .5%.
Demographic data and clinical data
Demographic and clinical data of study patients were collected from medical records that were reviewed by three experienced cardiologists. Cardiovascular risk factors, including systemic hypertension, hypercholesterolemia, diabetes mellitus and smoking habit were assessed. Systemic hypertension was defined as blood pressure " 140/90 mmHg or medically treated. Hypercholesterolemia was defined as total cholesterol " 220 mg/dL, low-density lipoprotein cholesterol " 140 mg/dL, high-density lipoprotein cholesterol ! 40 mg/ dL, fasting triglycerides " 150 mg/dL, or medically treated. Diabetes mellitus was defined as fasting plasma glucose " 126 mg/dL, postprandial blood glucose " 200 mg/dL, or medically treated. Smoking habit was defined as smoking >2 pack-years. Weight, height, and body mass index were also assessed. Body mass index was defined as body weight (kg) divided by the square of the height (m). Patients were also evaluated for concurrent atrial fibrillation, dementia, old myocardial infarction, arteriosclerosis obliterans, and underlying hemodialysis. Past medical history, including history of malignancy, history of percutaneous coronary intervention, history of coronary artery bypass grafting, and history of pacemaker implantation were also assessed. Use of medications [statins, anti-platelet agents, renin angiotensin system inhibitors (angiotensin converting enzyme inhibitors and angiotensin II receptor blockers), calcium channel blockers, beta blockers, warfarin, and diuretics] was also evaluated. The medical records of study patients were also reviewed for social background characteristics, and the following were assessed: activities of daily living, dwelling independently or in a nursing home, and reliance on public support. Patients who needed somebody's help for daily life were classified as "low activities of daily living".
Echocardiographic measurements
Baseline echocardiographic data were derived from echocardiographic reports before admission. Echocardiographic examinations were performed using a commerciallyavailable echocardiographic machine (Sonos 5500, Philips, Bothell, WA, USA). Patients underwent a two-dimensional examination by an experienced sonographer or cardiologist. Left ventricular ejection fraction was calculated by the following equation: 100 × (end-diastolic volume -end-systolic volume)/end-diastolic volume (6) . Left atrial dimensions, left ventricular end-diastolic dimension, interventricular septal wall thickness, and relative wall thickness were evaluated, in addition to left ventricular ejection fraction. The relative wall thickness was calculated using the following formula: [(posterior wall thickness + interventricular septal wall thickness)/left ventricular end-diastolic dimension] (6).
Physiological function tests
The lower value of the ankle-brachial index and the higher value of pulse wave velocity testing in the physiological test reports of the study patients were used in the evaluation.
Laboratory data
The laboratory data evaluated were white blood cell count, hemoglobin, RDW, C-reactive protein (CRP), creatinine, albumin and brain natriuretic peptide (BNP).
Statistical analysis
Results are expressed as means ± standard deviations or as numbers and proportions (%). On univariate analyses, continuous and categorical variables were compared using ttests and chi-squared tests, respectively. To search for the most predictive RDW cut-off point for HF, univariate logistic regression of HF risk on RDW was evaluated with different cut-off points. For constructing the final multivariate logistic model for predicting fatal HF risk, age, sex, and hemoglobin concentration were selected as variables. Variables with a p<0.10 on the univariate analyses were also entered into the multivariate logistic regression model. All statistical analyses were conducted using SAS Enterprise Guide 4 software (SAS Institute Inc., Cary, NC, USA). Statistical significance was defined as p<0.05.
Results
In total, 160 patients were included; the major causes of death were HF (32.5%, 52/160), CVD (28.8%, 46/160), and infectious disease (28.1%, 45/160). Table 1 shows the baseline cardiac diseases in patients with fatal HF. Table 2 shows the cause of death in patients without fatal HF. Table 3 shows the mean RDW values in patients with fatal HF, CVD without fatal heart failure, and non-CVD. No significant difference in the results was found among these three causes of death. P values between fatal HF and CVD, fatal HF and non-CVD, and CVD and non-CVD were 0.11, 0.31, and 0.39 respectively. When the RDW value was dichotomized at cut-offs of every 0.5% from 14.0% to 16.5%, the odds ratios (ORs) and 95% confidence interval (95% CI) for fatal HF were calculated by univariate logistic regression analyses ( Table 4 ). The best cut-off of RDW for fatal HF was ! 16.5%. Table 5 shows the comparison of the clinical data in patients with and without fatal HF. Continuous and categorical variables were compared using t-tests and chisquared tests, respectively. Table 6 shows the results of multivariate logistic regression analysis. The white blood cell count (p<0.01 on univariate analysis) was not entered into the multivariate logistic regression analysis because the white blood cell count shows a close correlation with the CRP value. BNP (p=0.04 on univariate analysis) was also not entered in the multivariate logistic regression analysis, because the number of BNP values was small (n=78).
Discussion
The primary finding of the present study was that RDW ! 16.5 was significantly associated with fatal HF in superelderly patients. The average RDW is generally higher in super-elderly patients than in middle-aged and elderly patients (7, 8) . To determine the best cut-off RDW value for HF is very important in the clinical setting in geriatric medicine in a rapidly aging population such as in Japan. Patel et al. reported that RDW was closely related to the elevation of CRP, fibrinogen, and white blood cell count. The report suggested that chronic inflammation might contribute to the elevate RDW level (9) . But, to the contrary, a significant relationship between lower CRP and fatal HF was found by multivariate analysis in the present study. The different result obtained in our study came most probably from the rather mixed study population that included patients who died mainly of infection as well as those who died of heart failure in our institute. The negative correlation between fatal HF and higher CRP was accounted for by infection that was the major cause of non-cardiac deaths in our study population (approximately 30%, 45/160). Although the exact mechanism underlying the association of RDW with fatal HF is not clarified yet, systemic factors that alter erythrocyte homeostasis, such as inflammation or oxidative damage, can be assumed to play a certain role (9) (10) (11) . RDW is a useful marker not only for HF but also for atherosclerotic disease such as coronary artery disease (3, 4) and carotid artery atherosclerosis (12) .
RDW is routinely evaluated in the complete blood cell count. It is an inexpensive and convenient examination (13) . Moreover, an advantage of RDW is that it is not affected by renal function. Although BNP and NT-pro BNP are widely accepted measures of severe HF (14-16), most geriatric pa- tients who had HF had concomitant chronic kidney disease, and the severity of HF may be overestimated by BNP or NT-pro BNP in these patients. In addition to the BNP concentration, a high NYHA (New York Heart Association) classification is also a widely accepted predictor of poor outcome in chronic HF (17) . According to a previous study, the mortalities of patients with NYHA II, III, and IV classifications were 7.1%, 15.0%, and 28.0%, respectively (18).
The mean age in our study population was 84 years, approximately 10 years higher than in the previous study population. In the present study, approximately 30% (47/ 160) of study patients had dementia and could not explain their dyspnea symptoms correctly, so that it is difficult to determine whether dyspnea deteriorated in these patients. Although reduced left ventricular ejection fraction is also a widely accepted predictor of poor outcome in chronic HF (19, 20) , it is not a suitable marker for geriatric patients because they tend to have HF due to diastolic left ventricular dysfunction caused by atrial fibrillation, hypertension, and so on (21).
The limitations of the present study are its retrospective nature involving review of medical charts, its small size, and the fact that it was a single-center study. Our study population was rather mixed regarding cause of death as mentioned above and it may not reflect the general super-elderly population. We think it is necessary to compare RDW value of patients with HF and that of the general super-elderly population. Moreover, although determining an "optimal" cut-off point by dichotomizing variables iteratively at different values has been criticized (22, 23) , this method was used to simply investigate whether RDW can be an independent predictor of HF. To determine the optimal cut-off point for use in clinical practice needs future work, and it may be done by flexible trend-modeling analyses. Furthermore, we should have evaluated left ventricular diastolic dysfunction using multiple echocardiographic markers, such as mitral inflow or tissue Doppler imaging. In addition, the number of patients whose BNP was evaluated was too small to arrive at any definitive conclusions. Finally, while we screened the cause of death or baseline cardiac diseases through detailed review of medical charts in addition to confirming death certificates, it was difficult to reliably assess the cause of HF and distinguish HF death from death due to multiple organ failure, especially in super-elderly patients. Therefore, a large prospective study is necessary to validate the results of the present study.
It is important to focus on RDW values in daily clinical practice, since an RDW ! 16.5 is a predictor of fatal heart failure in super-elderly patients.
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